Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16449618 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Immune ablation and hematopoietic stem cell support.

Indicates status has not been verified in more than two years